In order to validate these findings in vivo and to test their functional relevance in the context of atherosclerosis, we created a novel transgenic mouse line with conditional endothelial-specific PRAS40 deficiency, based on cre/loxP-mediated mutagenesis (EC-PRAS40-KO). The gene discussed is AKT1S1; the disease is atherosclerosis.